Drug: Tapentadol Prolonged Release: chronic pain clinical trials

Registry records that list "Drug: Tapentadol Prolonged Release" as an intervention. Being studied does not mean an intervention works or is approved.

Trials with Canadian sites

Recruiting in Canada

Registry records in total

Trials in Canada

No trial with a Canadian site lists this intervention in this snapshot.

5 trials, 0 recruiting or not yet recruiting. Recruiting first.

		Phase	Countries
A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain NCT02151682	Completed	Phase 2, Phase 3	Belgium, Bulgaria, Chile, France and 6 more	Grünenthal GmbH	2015-04-29
Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component. NCT01838616	Completed	Phase 4	Austria, Germany, Italy, Spain	Grünenthal GmbH	2013-04
Tapentadol in Chronic Malignant Tumour Related Pain NCT01264887	Terminated	Phase 3	Bulgaria, Hungary, Moldova, Poland and 3 more	Grünenthal GmbH	2011-03
Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin NCT01352741	Completed	Phase 4	Austria, Belgium, Denmark, Germany and 3 more	Grünenthal GmbH	2011-03
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability NCT00986258	Terminated	Phase 3	Belgium, Czechia, France, Germany and 4 more	Grünenthal GmbH	2009-10-30

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.